Kevin E. Weddington

Array ( [id] => 4323865 [patent_doc_number] => 06312663 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Prediction of diabetes impaired wound healing by urinary nitrate assay' [patent_app_type] => 1 [patent_app_number] => 9/516584 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6272 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312663.pdf [firstpage_image] =>[orig_patent_app_number] => 516584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440266 [patent_doc_number] => 06495532 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/381489 [patent_app_country] => US [patent_app_date] => 2000-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44034 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495532.pdf [firstpage_image] =>[orig_patent_app_number] => 09381489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326233 [patent_doc_number] => 06329343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Bioadhesive antibacterial wound healing composition' [patent_app_type] => 1 [patent_app_number] => 9/511869 [patent_app_country] => US [patent_app_date] => 2000-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4957 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329343.pdf [firstpage_image] =>[orig_patent_app_number] => 511869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462926 [patent_doc_number] => 06350769 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Gaba alpha receptors mediate inhibition of T cell responses' [patent_app_type] => B1 [patent_app_number] => 09/513259 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350769.pdf [firstpage_image] =>[orig_patent_app_number] => 09513259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4312776 [patent_doc_number] => 06316481 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Pharmaceutical composition containing proton pump inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/510312 [patent_app_country] => US [patent_app_date] => 2000-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1690 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316481.pdf [firstpage_image] =>[orig_patent_app_number] => 510312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561773 [patent_doc_number] => 06362202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Methods and compositions using () norcisapride in combination with proton pump inhibitors or H2 receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/507951 [patent_app_country] => US [patent_app_date] => 2000-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8627 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362202.pdf [firstpage_image] =>[orig_patent_app_number] => 09507951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524067 [patent_doc_number] => 06353005 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Method and compositions using () norcisapride in combination with proton pump inhibitors or H2 receptor antagonist' [patent_app_type] => B1 [patent_app_number] => 09/507965 [patent_app_country] => US [patent_app_date] => 2000-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8607 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353005.pdf [firstpage_image] =>[orig_patent_app_number] => 09507965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 956293 [patent_doc_number] => 06956044 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-18 [patent_title] => 'Compositions and methods for treatment of epilepsy' [patent_app_type] => utility [patent_app_number] => 10/204605 [patent_app_country] => US [patent_app_date] => 2000-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3089 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/956/06956044.pdf [firstpage_image] =>[orig_patent_app_number] => 10204605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790633 [patent_doc_number] => 06984655 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'Photodynamic therapy for selectively closing neovasa in eyeground tissue' [patent_app_type] => utility [patent_app_number] => 10/203420 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19880 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 650 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984655.pdf [firstpage_image] =>[orig_patent_app_number] => 10203420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433382 [patent_doc_number] => 06340672 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Parasiticidal formulation and a method of making this formulation' [patent_app_type] => B1 [patent_app_number] => 09/504830 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4738 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340672.pdf [firstpage_image] =>[orig_patent_app_number] => 09504830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586247 [patent_doc_number] => 06358975 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Method of using selective parp inhibitors to prevent or treat neurotoxicity' [patent_app_type] => B1 [patent_app_number] => 09/502046 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8449 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358975.pdf [firstpage_image] =>[orig_patent_app_number] => 09502046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379638 [patent_doc_number] => 06303572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Control of acidic gut syndrome' [patent_app_type] => 1 [patent_app_number] => 9/446801 [patent_app_country] => US [patent_app_date] => 2000-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17518 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303572.pdf [firstpage_image] =>[orig_patent_app_number] => 446801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521437 [patent_doc_number] => 06414036 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Composition for treatment of infections of humans and animals' [patent_app_type] => B1 [patent_app_number] => 09/499197 [patent_app_country] => US [patent_app_date] => 2000-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 14915 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414036.pdf [firstpage_image] =>[orig_patent_app_number] => 09499197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014715 [patent_doc_number] => 06894058 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-17 [patent_title] => 'Use of 3-hydroxy-3-methylgutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy' [patent_app_type] => utility [patent_app_number] => 09/889409 [patent_app_country] => US [patent_app_date] => 2000-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3644 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894058.pdf [firstpage_image] =>[orig_patent_app_number] => 09889409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1566889 [patent_doc_number] => 06376512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Therapeutic uses of quinoline derivatives' [patent_app_type] => B1 [patent_app_number] => 09/490897 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 24310 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376512.pdf [firstpage_image] =>[orig_patent_app_number] => 09490897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380729 [patent_doc_number] => 06303644 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Proton pump inhibitor in therapeutic combination with antibacterial substances' [patent_app_type] => 1 [patent_app_number] => 9/463390 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1214 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303644.pdf [firstpage_image] =>[orig_patent_app_number] => 463390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268797 [patent_doc_number] => 06306838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Targeted vesicular constructs for cyto protection and treatment of h. pylori' [patent_app_type] => 1 [patent_app_number] => 9/490127 [patent_app_country] => US [patent_app_date] => 2000-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4682 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306838.pdf [firstpage_image] =>[orig_patent_app_number] => 490127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272862 [patent_doc_number] => 06323203 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Composition and method for treating diabetes' [patent_app_type] => 1 [patent_app_number] => 9/487217 [patent_app_country] => US [patent_app_date] => 2000-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6061 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323203.pdf [firstpage_image] =>[orig_patent_app_number] => 487217 [rel_patent_id] =>[rel_patent_doc_number] =>)